Emerging Markets Regulatory Tracker: Australia, China (Vol. 4 No. 28)
This article was originally published in PharmAsia News
Executive Summary
Australia’s TGA has announced a one-year extension to submit reclassification applications for partial total hip, knee and shoulder joint implants. In China, the FDA issued notices on a voluntary recall of medical devices from GE Medical Systems and Smith & Nephew.